Search results

Clinical Research Study on Pre natal Supplementation

Reducing the Risk of Asthma Using Incromega™ TG3322

Striving for Global Manufacturing Excellence

Croda Inc proudly announces that its manufacturing sites in New Castle, Delaware and Mill Hall, Pennsylvania have been awarded the EFfCI’s (The European Federation for Cosmetic Ingredients) GMP (Good Manufacturing Practice) certification.

11th Most Sustainable International Company

We are celebrating being ranked the top of the chemicals sector for the sixth year running in Britain’s Most Admired Companies award

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

EcoVadis Rates Crodas Environmental Practices as Outstanding

Croda has been awarded EcoVadis Gold Status for the fourth time

EcoVadis Gold Status for the Third Year Running

Croda, who create, make and sell innovative, sustainable, high performance speciality chemicals that are relied on by industries and consumers everywhere has this month been awarded EcoVadis Gold Status for the third year running.

Sustainability success with EcoVadis rating

24 May 2022: Sustainability success after retaining its position within the top 1% of companies assessed by EcoVadis

Croda retains top spot as Britain’s most admired Chemicals Company

19 March 2024: Croda International Plc maintains its top spot as 'Britain’s Most Admired Chemicals Company' for the seventh consecutive year.

Contact investor relations

Receive investor relations updates.

Croda opens new manufacturing facility in Dahej, India to support growth and sustainable innovation

Croda inaugurates a new greenfield manufacturing facility in Dahej, India, expanding its capacity to deliver high-performance, science-driven solutions to fast-growing Asian markets.

Sustainability

Sustainability spans every area of our business and is a crucial way we add value to our customers.

Meet the expert: Will Small, Research & Technology Specialist

Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.

Australia

The availability of high quality wool grease, the raw material from which lanolin is manufactured, fuelled Croda’s move into Australia in 1968.

Our sustainability leadership

Discover how Croda are driving deeper impact to create greater value across fewer targets.

Chief Executive's Statement 2025

An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.

Specialist biotechnology capabilities

At Croda, thanks to our expertise across a wide range of biotechnology specialisms, we are developing new, innovative and sustainable ingredients to support our customers in bringing to market exciting often niche products.

Shaping the next generation: Industrial Placements at Croda

Join us as we recognise our Industrial Placement students, their success and their views on our placement opportunities.

Investor overview

Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.

CrodaTherm helps COVID 19 ICU nurses in the United States

Croda donates cooling vests to Christiana Care Hospital in Newark, Delaware

Steve Foots, Group Chief Executive Letter

We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.

Abiotic stress mitigation in onions

Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.

Investor seminar on our Life Sciences sector

7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.

Driving consistent growth

Procurement and sustainable sourcing

Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.

Croda expands biopharma capabilities through strategic partnership

9 December 2025: Croda International Plc  today announces a strategic supply partnership with Amino GmbH (“Amino”), a leading manufacturer of pharmaceutical-grade amino acids

Croda acquires Inventiva, encapsulation and delivery system technology

It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.

Strengthening Life Sciences with the acquisition of Avanti Polar Lipids

A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.

Strategic investment Entekno Materials

A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.

Croda joins forces with academic experts to develop sustainable polymers for a clean future

Croda International Plc and the Universities of Nottingham and York have today announced a collaborative partnership to develop novel, sustainable polymers for liquid formulations.

Symiro™ biostimulant

As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.

Croda becomes founding member of sustainability Business Transformation Group

We are proud to be a founding member of the CISL Business Transformation Group.

Croda joins the Together for Sustainability initiative

Croda becomes the 30th member of TfS

Contract for innovative delivery system for COVID19 vaccine

We have recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.

Croda invests in biopharma innovation with expanded Super Refined™ facility in Leek, UK

25 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, continues to invest in the evolving world of biopharmaceutical manufacturing where consistency and purity in ingredients are critical.

Record performance driven by accelerated strategic implementation

Croda International results for the six months ended 30 June 2021

First quarter 2025 sales update

23 April 2025: Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2025 (the three months ended 31 March 2025).

Croda’s first product launch specifically focusing on the biopesticide market

28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.

C4C Lead via SnapEngage

C4C Lead via SnapEngage

Life Sciences

We provide high-quality healthcare solutions, protect crops, and enhance seeds, supporting global health and crop sustainability. Our growing range of technologies ensures we deliver high value to customers worldwide.

Consumer Care

Consumer Care combines our businesses closest to consumers, offering innovative, sustainable solutions for home care, beauty, personal care, and fragrance. Our expertise enables us to provide tailored formulations to meet global consumer demands.

Pharma seminar

7 October 2022: Investor seminar, empowering biologics delivery in Pharma

Fragrances & Flavours investor site visit

12 May 2022: Presentation articulating the compelling growth plan for our F&F business as part of an investor site visit.

First quarter 2024 results call

Update on trading from 01 January to 31 March.

Transition to a dedicated Consumer Care and Life Sciences company

Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company

Full year 2022 results

Powerful operating model and consistent execution delivers record performance.

Oil and Gas Portfolio Strengthened by Acquisition

Global speciality chemical manufacturer Croda, announces the acquisition of JD Horizons Limited, a UK based business specialising in ‘Solutions for Flow Assurance’ technology.

Croda breaks ground on new manufacturing facility for pharmaceutical excipients

5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.

Croda announces Global Technical Centre in Hyderabad

5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.

Continued recognition for environmental efforts in FTSE4Good Index Series

22 August 2022: Acknowledging our strong sustainability focus, we continue to be included in the FTSE4Good Index series.

Half year 2023 results

Continued investment and strategic progress despite a challenging environment.

Croda voted most admired company in the British Chemical Sector

1 March 2022: Croda International Plc, is today celebrating, once again, being voted Britain’s Most Admired Chemicals Company.

Investor seminars and events

Collateral and information from our regular shareholder events.

Behind the Science

Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.

Brazil

Croda do Brasil was established in 1974 and the Campinas manufacturing site in 1977.

Your ingredients partner powering health innovation

Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.

Croda strengthens commitment to help customers decarbonise with updated Science Based Targets by 2030 and approved Net Zero target by 2050 

26 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today announced updated climate goals that have been externally validated by the Science Based Targets initiative (SBTi)

New frontiers in fragrance and flavours

Croda acquired international fragrances and flavours company Iberchem in 2020, the largest acquisition in our history and a major move into a market strongly aligned with our business.

Our Commitment

Croda is committed to being Climate, Nature, and People Positive by 2030, integrating sustainability into its core practices to positively impact the environment and society for a healthier planet and future generations.

Croda launches animated timeline to showcase 100 years of innovation

13 February 2025: Croda today launches an animated historical timeline to mark its centenary year.

100 years of smart science: Celebrating Croda's centenary at our headquarters

Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.

2024 Annual Report

Access Croda's latest annual report for comprehensive insights into our performance and strategic direction. Stay informed with our investor resources.

2025 Annual Report

Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.

Biotechnology at Croda

Our innovation is focused on sustainability and, in particular, biotechnology, enhancing the sustainability of our processes and products.

Our heritage

Founded in 1925, we continue to build on our heritage every day, with sustainability always central to our thinking, turning exciting and often ground-breaking ideas into practical solutions for our customers.

Our Purpose

At Croda, our purpose is to use Smart science to improve lives™ through a values-led culture that shapes our work and partnerships. Our knowledge, passion, and entrepreneurial spirit drive the creation of specialty ingredients trusted by industries and consumers worldwide.

Our centenary

2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.

Croda develops young minds of tomorrow during COP26

We have launched new sustainability focused materials for children in STEM

About us

We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture

Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

ASD Kaleka Mosaik Initiative Impact Fund

We are contributing to the first Impact Fund of ASD, developed in partnership with Tides Foundation.

Regulatory news

Our most recent announcements to the stock exchange.

Externally validated avoided emissions

The emissions savings of this new product were revealed during its sustainability assessment, part of the new way of working for our innovation teams to support our Commitment.

Croda Beauty’s Natrineo™ CR8 wins silver for Best New Ingredient at The Pure Beauty Awards

24 October 2025: Croda International Plc  today announces that its groundbreaking, naturally-derived emulsifier, Natrineo™ CR8 has been awarded Silver for Best New Ingredient at the Pure Beauty Awards UK 2025.

Key Performance Indicators

Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

Danuta Gray, Chair's Letter 2024

The Board and shareholders are aligned that the Company’s priorities should be execution and operational delivery to grow earnings and improve returns on invested capital.

Consumer Care business review

Discover how Consumer Care is reinvigorating Beauty and enabling continued growth in Fragrances & Flavours. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.

Supporting Invisible Disabilities Week at Croda

Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.

Advancing the efficacy and impact of vaccines

The acquisition of Biosector in 2018 strengthened our pharmaceutical offering, taking us into the field of vaccine adjuvants.

Flue2Chem

In another example of industry-wide collaboration to help tackle the climate emergency, the Flue2Chem Innovate UK project aims to demonstrate that a UK supply chain to produce alkoxylated surfacants from CO2 is economically and technically feasible.

Digitalisation in manufacturing

We can see the potential of big data, robotics, analytics and the Internet of Things to drive manufacturing excellence and contribute to our right first time agenda.

Net zero roadmap for UK manufacturing site

We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.

Life cycle assesment

Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.

Leveraging expertise in UV filters for Asian markets

There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our sustainability Commitment to be People Positive by 2030.

Human Performance programme

Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.

Croda Foundation

We have taken a big step towards achieving our ambition of expanding the reach of our smart science to permanently improve more lives by funding the Croda Foundation.

Collaboration to deliver new vaccine adjuvants

In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).

Navigating the future of innovative ingredients

As Croda celebrates 100 years of delivering Smart science to improve lives™, we’re also looking ahead. This Vision Report is a forward-looking guide to the trends that will reshape the speciality ingredients industry across the next quarter-century.

Responsible business

/Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image

100 years of smart science: Celebrating Croda's centenary across the globe

Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.

Supporting the next generation of therapeutic vaccines

Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.

Bringing anti-ageing benefits to make-up

Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.

Collaboration to develop alternative vaccine adjuvants

In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).

International Day of Women and Girls in Science

At Croda, we recognise that by championing gender equality in STEM, we can adopt a future where talent determines success; while promoting inclusivity, and empowering the next generation of female scientists, engineers, and innovators.

Site visit to Sederma Beauty Actives business in France

17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.

Our Board activity in 2025

An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.

Ratings and frameworks

View our ratings and frameworks which help to shape our sustainability programme.

Croda unveils new data for Crodabond™ CSN: effective SPF boosting for high performance sun care

3 November 2025: Croda International Plc  has has recently unveiled new SPF-boosting data for Crodabond™ CSN.

Celebrating a century of Croda

Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.

Croda acquired crop enhancement company Plant Impact

Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

Croda acquires research enterprise Enza Biotech

Developing the next generation of renewable surfactants using carbohydrate-based chemistry.